AMANDA CENICEROS: Open Payments
NPI 1588340657 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 75 payments from 20 companies in 2025. Trend: 2023 $154 · 2024 $1,461 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $204 |
| Amgen Inc. | 12 | $164 |
| ABBVIE INC. | 9 | $162 |
| PFIZER INC. | 11 | $158 |
| GlaxoSmithKline, LLC. | 6 | $123 |
| Merck Sharp & Dohme LLC | 4 | $87 |
| Novo Nordisk Inc | 4 | $71 |
| Lilly USA, LLC | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: TRELEGY ELLIPTA, BREZTRI, EVENITY, VRAYLAR, GARDASIL 9, NURTEC ODT, AIRSUPRA, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
